Benralizumab for eosinophilic gastritis: a single-site, randomised, double-blind, placebo-controlled, phase 2 trial

Kara Kliewer, Cristin Murray-Petzold, Margaret H. Collins, J. Pablo Abonia, Scott M. Bolton, Lauren DiTommaso, Lisa J. Martin, Xue Zhang, Vincent A. Mukkada, Philip E. Putnam, Erinn S. Kellner, Ashley L. Devonshire, Justin T. Schwartz, Vidhya Kunnathur, Chen Rosenberg, John L. Lyles, Tetsuo Shoda, Amy D. Klion, Marc E. Rothenberg